[Transdermal rotigotine as monotherapy for Parkinson disease].
Wasielewski
Susanne
S
D000279:Administration, Cutaneous; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D013764:Tetrahydronaphthalenes; D013876:Thiophenes; C047508:rotigotine